Adachi Y, Hashimoto K, Hisa H, Yoshida M, Suzuki-Kusaba M, Satoh S
Department of Pharmacology, Tohoku University, Sendai, Japan.
Eur J Pharmacol. 1996 Jul 18;308(2):165-71. doi: 10.1016/0014-2999(96)00298-1.
Intrarenal arterial infusion of angiotensin II (4 ng/kg/min) reduced renal blood flow, glomerular filtration rate and urinary Na+ excretion (UNaV) without affecting fractional Na+ excretion (FENa) in anesthetized rabbits. Losartan (10 micrograms/kg/min) abolished these angiotensin II-induced renal responses. The renal blood flow, glomerular filtration rate and UNaV responses were potentiated during intrarenal arterial infusion of N omega-nitro-L-arginine methyl ester (L-NAME, 10 micrograms/kg/min). A high dose of L-NAME (50 micrograms/kg/min) also potentiated the renal blood flow and UNaV responses but not the glomerular filtration rate response. Angiotensin II reduced FENa during L-NAME infusion at either dose. In L-NAME-pretreated rabbits, losartan abolished the angiotensin II-induced renal blood flow and glomerular filtration rate responses, but the reduction in FENa still remained. The present study suggests that in the rabbit kidney (1) nitric oxide attenuates the angiotensin II-induced (angiotensin AT1 receptor-mediated) vasoconstriction and (2) angiotensin II can evoke losartan-resistant tubular Na+ reabsorption, but the tubular action is concealed by nitric oxide.
在麻醉兔中,肾内动脉输注血管紧张素II(4纳克/千克/分钟)可降低肾血流量、肾小球滤过率和尿钠排泄量(UNaV),而不影响钠排泄分数(FENa)。氯沙坦(10微克/千克/分钟)可消除血管紧张素II诱导的这些肾脏反应。在肾内动脉输注Nω-硝基-L-精氨酸甲酯(L-NAME,10微克/千克/分钟)期间,肾血流量、肾小球滤过率和UNaV反应增强。高剂量的L-NAME(50微克/千克/分钟)也增强了肾血流量和UNaV反应,但未增强肾小球滤过率反应。在两种剂量的L-NAME输注期间,血管紧张素II均降低了FENa。在L-NAME预处理的兔中,氯沙坦消除了血管紧张素II诱导的肾血流量和肾小球滤过率反应,但FENa的降低仍然存在。本研究表明,在兔肾中:(1)一氧化氮减弱血管紧张素II诱导的(血管紧张素AT1受体介导的)血管收缩;(2)血管紧张素II可引起氯沙坦抵抗的肾小管钠重吸收,但肾小管作用被一氧化氮掩盖。